Works matching IS 22965270 AND DT 2025 AND VI 48 AND IP 3

Results: 12

Front & Back Matter.

Published in:: Oncology Research & Treatment, 2025, v. 48, n. 3, p. 1, doi. 10.1159/000545057
Publication type:: Article

ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM.

Published in:: Oncology Research & Treatment, 2025, v. 48, n. 3, p. 150, doi. 10.1159/000544715
Publication type:: Article

Capivasertib + Fulvestrant beim metastasierten Brustkrebs.

Published in:: Oncology Research & Treatment, 2025, v. 48, n. 3, p. 148, doi. 10.1159/000544713
Publication type:: Article

Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Targeted Therapies in Non-Small Cell Lung Cancer.

Published in:

2025

By:

Webendörfer, Maximilian;
Heinzen, Sophie;
Sibbert, Christine;
Leßmann, Marie-Elisabeth;
Kropf-Sanchen, Cornelia;
Thomas, Michael;
Tufman, Amanda;
Bleckmann, Annalen;
Wiesweg, Marcel;
Griesinger, Frank;
Reitnauer, Lea;
Overbeck, Tobias Raphael

Publication type:

Letter

Prognostic Significance of HER2 Positivity in Endometrium Cancer.

Published in:

Oncology Research & Treatment, 2025, v. 48, n. 3, p. 75, doi. 10.1159/000542900

By:

Sekmek, Serhat;
Bayram, Dogan;
Karahan, Irfan;
Seven, Ismet;
Perkin, Perihan;
Muftuoglu, Kamil Hakan;
Bal, Oznur;
Yalcin, Bulent;
Uncu, Dogan;
Algin, Efnan

Publication type:

Article

PharmaNews.

Published in:: Oncology Research & Treatment, 2025, v. 48, n. 3, p. 152, doi. 10.1159/000544573
Publication type:: Article

Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy.

Published in:

Oncology Research & Treatment, 2025, v. 48, n. 3, p. 112, doi. 10.1159/000543137

By:

Li, Zhensheng;
Chen, Liang;
Han, Huina;
Shang, Yuguang;
Li, Yue;
Jia, Zhifeng;
Liu, Yunjiang

Publication type:

Article

The Diagnostic Utility of cfDNA and ctDNA in Liquid Biopsies for Gastrointestinal Cancers over the Last Decade.

Published in:

Oncology Research & Treatment, 2025, v. 48, n. 3, p. 125, doi. 10.1159/000543030

By:

Rahadiani, Nur;
Stephanie, Marini;
Manatar, Amelia Fossetta;
Krisnuhoni, Ening

Publication type:

Article

Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors.

Published in:

Oncology Research & Treatment, 2025, v. 48, n. 3, p. 82, doi. 10.1159/000542958

By:

Nieder, Carsten;
Aanes, Siv Gyda;
Stanisavljevic, Luka;
Mannsåker, Bård;
Haukland, Ellinor Christin

Publication type:

Article

Society Bulletins.

Published in:: Oncology Research & Treatment, 2025, v. 48, n. 3, p. 156, doi. 10.1159/000544116
Publication type:: Article

Navigating Gynecological Oncology with Different Versions of ChatGPT: A Transformative Breakthrough or the Next Black Box Challenge?

Published in:

Oncology Research & Treatment, 2025, v. 48, n. 3, p. 102, doi. 10.1159/000543173

By:

Gungor, Nur Dokuzeylul;
Esen, Fatih Sinan;
Tasci, Tolga;
Gungor, Kagan;
Cil, Kaan

Publication type:

Article

Epidemiology, Real-World Treatment Patterns, and Patient Outcomes of Primary Advanced or Recurrent Endometrial Cancer in Germany between 2015 and 2021.

Published in:

Oncology Research & Treatment, 2025, v. 48, n. 3, p. 92, doi. 10.1159/000542773

By:

Mevius, Antje;
Lutter, Johanna;
Karl, Florian M.;
Tuffy, Liam;
Schochter, Fabienne;
Fuchs, Andreas;
Wilke, Thomas

Publication type:

Article